We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Development Study Using Vaginal Tactile Imager

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01111916
Recruitment Status : Completed
First Posted : April 28, 2010
Last Update Posted : February 25, 2014
Information provided by (Responsible Party):

March 22, 2010
April 28, 2010
February 25, 2014
March 2010
September 2010   (Final data collection date for primary outcome measure)
To determine whether there is a detectable difference in 3-D elasticity images provided by Vaginal Tactile Imager for the patients with presence or absence of prolapse. [ Time Frame: 1 Year ]
Same as current
Complete list of historical versions of study NCT01111916 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Development Study Using Vaginal Tactile Imager
A Development Study Using Vaginal Tactile Imager to Assess the Elasticity Properties of the Vaginal Wall and Surrounding Connective Tissue
The objective is to evaluate and optimize tactile imaging technology in evaluation of tissue elasticity parameters in the female pelvis.
Pelvic organ prolapse affects 40-50% of women in US. This study aims to establish a reliable examination procedure, collect data necessary for assessing the performance of Vaginal Tactile Imaging sensors, assess clinical suitability of interface software and correlate elasticity measurements with clinical examination findings for normal versus prolapse conditions of the female pelvis.
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Adult women with normal pelvic anatomy
Pelvic Organ Prolapse
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
September 2010
September 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. no evidence of pelvic organ prolapse and no prior pelvic surgery
  2. stage 1 or greater pelvic organ prolapse affecting one or more vaginal compartments
  3. no evidence of pelvic organ prolapse with prior pelvic surgery (with or without the use of graft material)

Exclusion Criteria:

  1. patients with active skin infection, tissue breakdown or ulceration
  2. patients with abnormal vaginal anatomy, including vaginal septum, history of vaginal/pelvic radiation, presence of a vaginal tumor or lesion
  3. recent pelvic surgery with less than 3-month interval from surgery
Sexes Eligible for Study: Female
21 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
United States
VTI 02
1R43AG034714-01 ( U.S. NIH Grant/Contract )
Not Provided
Not Provided
Artann Laboratories
Artann Laboratories
  • National Institute on Aging (NIA)
  • Princeton Healthcare System
Principal Investigator: Vladimir Egorov, PhD Artann Laboratories
Artann Laboratories
February 2014